Identification of the molecular attributes required for aminoglycoside activity against Leishmania

Shalev M.; Kondo J.; Kopelyanskiy D.Jaffe C.L.Adir N.Baasov T.

首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Identification of the molecular attributes required for aminoglycoside activity against Leishmania

【24h】

Identification of the molecular attributes required for aminoglycoside activity against Leishmania

机译：Identification of the molecular attributes required for aminoglycoside activity against Leishmania

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相关主题

摘要

Leishmaniasis, a parasitic disease caused by protozoa of the genus Leishmania, affects millions of people worldwide. Aminoglycosides are mostly known as highly potent, broad-spectrum antibiotics that exert their antibacterial activity by selectively targeting the decoding A site of the bacterial ribosome, leading to aberrant protein synthesis. Recently, some aminoglycosides have been clinically approved and are currently used worldwide for the treatment of leishmaniasis; however the molecular details by which aminoglycosides induce their deleterious effect on Leishmaina is still rather obscure. Based on high conservation of the decoding site among all kingdoms, it is assumed that the putative binding site of these agents in Leishmania is the ribosomal A site. However, although recent X-ray crystal structures of the bacterial ribosome in complex with aminoglycosides shed light on the mechanism of aminoglycosides action as antibiotics, no such data are presently available regarding their binding site in Leishmania. We present crystal structures of two different aminoglycoside molecules bound to a model of the Leishmania ribosomal A site: Geneticin (G418), a potent aminoglycoside for the treatment of leishmaniasis at a 2.65-? resolution, and Apramycin, shown to be a strong binder to the leishmanial ribosome lacking an antileishmanial activity at 1.4-? resolution. The structural data, coupled with in vitro inhibition measurements on two strains of Leishmania, provide insight as to the source of the difference in inhibitory activity of different Aminoglycosides. The combined structural and physiological data sets the ground for rational design of new, and more specific, aminoglycoside derivatives as potential therapeutic agents against leishmaniasis.

著录项

来源
《Proceedings of the National Academy of Sciences of the United States of America》 |2013年第33期|13333-13338|共6页
作者
Shalev M.; Kondo J.; Kopelyanskiy D.Jaffe C.L.Adir N.Baasov T.;
展开▼
作者单位

Schulich Faculty of Chemistry, Technion-Israel Institute of Technology, Haifa 32000, Israel;

Department of Materials and Life Sciences, Faculty of Science and Technology, Sophia University, Tokyo 102-8554, Japan;

Department of Microbiology and Molecular Genetics, Institute for Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel;

展开▼
收录信息美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
原文格式 PDF
正文语种英语
中图分类自然科学总论;
关键词
Leishmania growth inhibition; Ribosomal decoding site; X-ray analysis;

Identification of the molecular attributes required for aminoglycoside activity against Leishmania

摘要

著录项

相关主题

期刊订阅